Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial

[1]  E. Agabiti.  The Systolic Blood Pressure Intervention Trial , 2016 .

[2]  Nicholette D. Palmer,et al.  Gene-gene interactions in APOL1-associated nephropathy. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[3]  S. Gabriel,et al.  Increased Burden of Cardiovascular Disease in Carriers of APOL1 Genetic Variants , 2014, Circulation research.

[4]  John D Reveille,et al.  End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1 , 2014, Arthritis & rheumatology.

[5]  M. Budoff,et al.  Calcium density of coronary artery plaque and risk of incident cardiovascular events. , 2014, JAMA.

[6]  Barry I. Freedman,et al.  APOL1 risk variants, race, and progression of chronic kidney disease. , 2013, The New England journal of medicine.

[7]  M. Fornage,et al.  APOL1 variants associate with increased risk of CKD among African Americans. , 2013, Journal of the American Society of Nephrology : JASN.

[8]  Mardge H. Cohen,et al.  Host APOL1 genotype is independently associated with proteinuria in HIV infection , 2013, Kidney international.

[9]  M. Rocco,et al.  JC polyoma virus interacts with APOL1 in African Americans with non-diabetic nephropathy , 2013, Kidney international.

[10]  M. Beggs,et al.  Apolipoprotein L1 risk variants associate with systemic lupus erythematosus-associated collapsing glomerulopathy. , 2013, Journal of the American Society of Nephrology : JASN.

[11]  B. Astor,et al.  Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans , 2012, Kidney international.

[12]  K. Skorecki,et al.  Hypertension-misattributed kidney disease in African Americans. , 2013, Kidney international.

[13]  J. J. Rivera,et al.  Impact of coronary artery calcification on all-cause mortality in individuals with and without hypertension. , 2012, Atherosclerosis.

[14]  M. Rocco,et al.  Association of APOL1 variants with mild kidney disease in first-degree relatives of African American patients with non-diabetic end stage renal disease , 2012, Kidney international.

[15]  C. Langefeld,et al.  The new era of APOL1-associated glomerulosclerosis. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  D. Fine,et al.  APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease. , 2012, Journal of the American Society of Nephrology : JASN.

[17]  G. Genovese,et al.  Population-based risk assessment of APOL1 on renal disease. , 2011, Journal of the American Society of Nephrology : JASN.

[18]  J. O'Toole,et al.  APOL1 localization in normal kidney and nondiabetic kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.

[19]  A. Ashley-Koch,et al.  MYH9 and APOL1 are both associated with sickle cell disease nephropathy , 2011, British journal of haematology.

[20]  Giulio Genovese,et al.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[21]  D. Friedman,et al.  Genetics of kidney failure and the evolving story of APOL1. , 2011, The Journal of clinical investigation.

[22]  Keith C. Norris,et al.  Intensive blood-pressure control in hypertensive chronic kidney disease. , 2010, The New England journal of medicine.

[23]  C. Winkler,et al.  Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.

[24]  L. Appel,et al.  Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. , 2010, Journal of the American Society of Nephrology : JASN.

[25]  S. Rosset,et al.  Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene , 2010, Human Genetics.

[26]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[27]  Anna Velander Gisslén,et al.  Reference List , 2006, Mammalian Genome.

[28]  Wj Gauderman,et al.  QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies , 2006 .

[29]  N. Risch,et al.  Estimation of individual admixture: Analytical and study design considerations , 2005, Genetic epidemiology.

[30]  M. Kutner,et al.  Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK). , 2003, Journal of the American Society of Nephrology : JASN.

[31]  R. Toto,et al.  Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. , 1996, Controlled clinical trials.

[32]  Y. Hochberg.  A sharper Bonferroni procedure for multiple tests of significance , 1988 .